TABLE II.
A | |||||||
---|---|---|---|---|---|---|---|
Residues | Sequence | Detected | Length | MW | |||
DQ2DM+ | DQ2DM− | DR3DM+ | DR3DM− | ||||
Ii81-104 | LPKPPKPVSKMRMATPLLMQALPM | − | − | − | + | 24 | 2674.5 |
Ii81-103 | LPKPPKPVSKMRMATPLLMQALP | + | + | + | + | 23 | 2543.4 |
Ii82-103 | PKPPKPVSKMRMATPLLMQALP | + | + | − | + | 22 | 2430.4 |
Ii81-101 | LPKPPKPVSKMRMATPLLMQA | + | + | − | + | 21 | 2333.3 |
Ii93-109 | MATPLLMQALPMGALPQ | + | + | − | − | 17 | 1781.9 |
Ii93-108 | MATPLLMQALPMGALP | + | + | − | − | 16 | 1653.9 |
B | |||
---|---|---|---|
MHC II | Peptide | pmol | SD |
DQ2 (8.1.6) | Ii81-104 | ND | na |
Ii81-103 | 79,5 | 31,8 | |
Ii82-103 | 16,5 | 9,5 | |
Ii81-101 | 31,5 | 3,2 | |
Ii93-109 | ND | na | |
Ii93-108 | 159,0 | 1,1 | |
DQ2 (9.5.3) | Ii81-104 | ND | na |
Ii81-103 | 71,1* | 29,2 | |
Ii82-103 | 36,8* | 14,5 | |
Ii81-101 | 88,4* | 35,6 | |
Ii93-109 | 3,8 | 6,5 | |
Ii93-108 | 156,3 | 62,6 | |
DR3 (8.1.6) | Ii81-104 | ND | na |
Ii81-103 | 14,9 | 19,7 | |
Ii82-103 | ND | na | |
Ii81-101 | ND | na | |
Ii93-109 | ND | na | |
Ii93-108 | ND | na | |
DR3 (9.5.3) | Ii81-104 | 42,4 | 3,7 |
Ii81-103 | 128,3* | 23,3 | |
Ii82-103 | 113,3 | 22,3 | |
Ii81-101 | 106,1 | 8,0 | |
Ii93-109 | ND | na | |
Ii93-108 | ND | na |
Underestimated due to suboptimal ICPL labeling of eluted peptides from 9.5.3 cells. A rough estimation indicate that about 3% and 8% percent of total CLIP peptides remained unlabeled when eluted from DQ2 and DR3, respectively.